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Abstract
Purpose To assess the ophthalmological characteristics of
asymptomatic patients with a renal transplant on chronic
low-dose steroids for at least the last 2 years prior to
examination.
Methods Cross-sectional study. All patients underwent an ex-
tensive ophthalmological examination.
Results Of the 37 included patients [25 male, 12 female;
59 ± 11 years (range, 38–77 years)] ophthalmological pheno-
typing revealed abnormalities in 22 patients (59%). Findings
cha r ac t e r i s t i c f o r ( subc l i n i c a l ) c en t r a l s e rous
chorioretinopathy were detected in ten patients (27%), includ-
ing two patients with serous subretinal fluid in the macula. An
epiretinal membrane of the macula was present in six patients
(16%). Mean subfoveal choroidal thickness was significantly
increased in patients with ophthalmological abnormalities, in
comparison with patients without abnormalities.
Conclusions Retinal abnormalities are common in the major-
ity of renal transplant patients using chronic low-dose steroids.
These retinal changes may be associated with the renal disease
and/or the effect of chronic steroid use on the choroid and
retina.
Keywords Cross-sectional study . Renal transplant .
Ophthalmological examination . Retinal phenotyping .
Steroid use
Introduction
For end-stage solid organ disease, transplantation is a thera-
peutic option in a noteworthy number of patients. Abnormal
ophthalmological findings after several types of transplanta-
tion occur in more than 50% of patients [1–3], and are caused
by the combination of pre-existing disease and immunosup-
pressive regimen [4]. Fortunately, vision-threatening condi-
tions are seldom observed after long-term follow-up [5]. Up
to 45% of the transplant patients develop typical steroid-
induced bilateral posterior subcapsular cataract within the first
year after transplantation [1]. Bilateral, open-angle glaucoma
is detected in up to 7% of patients within the first year after
transplantation, which may be caused by the use of systemic
steroids [1]. Little is known about transplantation complica-
tions in the posterior segment of the eye. Documented retinal
complications are of infectious, hemorrhagic, or microvascu-
lar origin and have been described after bone marrow trans-
plantation preceded by total body irradiation [4]. Moreover,
optic disc edema and pigmentary changes have been found to
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occur after heart transplantation [6]. The kidney is the most
commonly transplanted organ worldwide. Little is known
about retinal abnormalities in renal transplant patients. Some
renal diseases that often require renal transplantation, for ex-
ample complement-associated diseases like dense deposit dis-
ease, are known to be associated with retinal abnormalities
such as drusen and macular degeneration [7]. Use of steroids
as is common after transplantation, is known to be a major risk
factor associated with central serous chorioretinopathy (CSC).
This is a form of macular degeneration caused by an accumu-
lation of serous subretinal fluid (SRF) due to choroidal and
retinal pigment epithelium (RPE) abnormalities [8–11].
Previous steroid intake has been described in up to 52% of
CSC patients, and odds ratios of up to 37 for CSC have been
found for steroid using subjects [8, 12, 13].
In the current study, we performed an extensive cross-
sectional ophthalmological phenotyping in renal transplant




In this cross-sectional study, 37 sequential outpatient renal trans-
plant patients who chronically used oral low-dose steroids for at
least 2 years prior to examination and who did not have visual
complaints were invited to take part in this study conducted at
the Department of Ophthalmology of the Leiden University
Medical Center, for ophthalmological analysis. Patients who
were previously diagnosed with either retinal abnormalities or
systemic disorders that may cause persistent retinal damage (for
example uncontrolled diabetes mellitus or uncontrolled hyper-
tension) were excluded.Written informed consent was signed by
all subjects. The study adhered to the tenets of the Declaration of
Helsinki, and was approved by the institutional review board
and the ethics committee (NL50816.058.14). Clinical informa-
tionwas collected from the patients’ charts. Patients were includ-
ed in this study from February 2016 to October 2016.
Ophthalmological imaging
Patients underwent an extensive ophthalmic assessment, in-
cluding Early Treatment of Diabetic Retinopathy Study
(ETDRS) best-corrected visual acuity (BCVA) measurement,
and indirect ophthalmoscopy. After administration of 1%
tropicamide and 5% phenylephrine drops, digital color fundus
photography of the central and peripheral retina (Topcon
Corp., Tokyo, Japan) was performed, and optical coherence
tomography (OCT), enhanced depth imaging (EDI-)OCT,
fundus autofluorescence, and oral fluorescein angiography
(FA) images were made with the spectral-domain OCT
(Spectralis HRA + OCT; Heidelberg Engineering, Dublin,
CA, USA). Subfoveal choroidal thickness (SFCT; distance
from the outer part of the hyperreflective RPE layer to the
hyperreflective line of the inner surface of the sclera) was
measured on EDI-OCT. For the oral FA, patients had to ingest
10 ml of 20% fluorescein after a fasting period of at least 3 h.
Oral FA images were obtained at 10, 15, 20, 25, and 30 min
after the administration of fluorescein. Peripheral images were
acquired between 25 and 30 min after ingestion. When the
evaluation of ophthalmological imaging by an experienced
retina specialist (CJFB) led to findings requiring treatment
and/or follow-up, these examinations and/or visits were
scheduled at the outpatient clinic of the Department of
Ophthalmology of Leiden University Medical Center.
Statistical analysis
For statistical analyses, descriptive statistics were used in SPSS
Statistics (version 23; IBM Corp., Armonk, NY, USA).
Independent t-tests were used to compare the patient group in
whom ophthalmological abnormalities could be detected to the
remaining patients for: need for and total duration of dialysis
before transplantation, reason of (re)transplantation, time from
the first renal transplantation (and start of steroid use) until
phenotyping, number of rejection therapies, type of immuno-
suppressive drugs at the moment of phenotyping, age of the
patient at the moment of transplantation and at phenotyping,
and donor age at the moment of transplantation. Moreover,
independent t-tests were used to compare the mean SFCT for
patients with and without ophthalmological abnormalities. The
level of statistical significance was set at p < 0.05.
Results
Patient characteristics
The mean age at phenotyping of the 37 included patients (25
male, 12 female) was 59 ± 11 years (range, 38–77 years). The
mean age at which the first renal transplantation had been
performed was 50 ± 12 years (range, 22–71 years).
Retransplantation had been performed in four patients
(11%). Eleven patients received a transplantation prior to di-
alysis. The total duration of dialysis was 3.2 ± 2.1 years
(range, 0.3–7.5 years) in the 24 other patients, for whom this
information was available.
Among other immunosuppressant medication, which was
used by all patients, all patients started using steroids after
their first transplantation. The estimated minimal cumulative
prednisolone dose was 4000 mg and the mean cumulative
prednisolone dose was 20,000 mg. At the moment of ophthal-
mological phenotyping, 25 patients used 5 mg and 12 used
7.5 mg prednisolone once daily. Eleven patients reported the
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use of other steroid-containing medication during the last year
before ophthalmological phenotyping. The medical history of
the participants was notable for arterial hypertension in all
patients (100%) and diabetes mellitus in 12 patients (32%).
Besides the diagnosis of a depression in three patients (8%),
no other diseases known to be possibly associated with CSC
were present [14]. Four patients used a mineralocorticoid re-
ceptor antagonist to treat hypertension, a drug which has also
been described as a therapeutic option for CSC [15]. Clinical
characteristics of the patients are summarized in Table 1.
Ophthalmic characteristics
At the visit to the Department of Ophthalmology, ETDRS
BCVAwas 84 ± 11 letters (range, 25–96 letters) in the included
eyes. Two patients had a history of unilateral amblyopia, and
one patient of recurrent unilateral herpes keratitis. In 60 eyes
(79%) ETDRS BCVA was ≥ 80 letters. During slit-lamp ex-
amination, unilateral mature cataract was detected in one pa-
tient. BCVA ETDRS in this patient improved from 25 to 85
ETDRS letters, after phacoemulsification. Besides the pres-
ence of pre-existing primary open-angle glaucoma in one pa-
tient, no other abnormalities of the anterior segment were
found. OCT showed the presence of macular serous SRF in
three eyes of two patients (5%). On FA, hyperfluorescent
changes that could fit well within the spectrum of
(subclinical) CSC were detected in these eyes, without the
presence of a ‘hot spot’ of leakage (Fig. 1a–e). Fundus auto-
f luorescence revea led var iab le mi ld hypo- and
hyperfluorescence of the lesions. On OCT imaging, a variable
degree of outer photoreceptor/RPE changes compatible with
subclinical CSC was found in eight of the remaining patients
(22%) , which was suppor ted by cor responding
hyperfluorescent changes on FA (Fig. 1f–j). On OCT imaging,
two patients had a bilateral epiretinal membrane (ERM), and
four had a unilateral ERM, resulting in a total of six patients
(16%) in whom an ERM in the macula was detected (Fig. 1w–
x). One of the patients with a unilateral ERM also had a mac-
ular pseudohole. Cuticular drusen, which are associated with
membranoproliferative glomerulonephritis type II (dense de-
posit disease), were seen in one patient with this disease (Fig.
1k–o), and multiple, small yellow-white lesions in the
midperiphery of the fundi, which are associated with Alport’s
disease, were seen in one patient with this diagnosis (Fig. 1u–
v) [16, 17]. Bilateral intermediate age-related macular degen-
eration with soft drusen and secondary vitelliform-like lesions
was found in one patient (Fig. 1p–t), whereas bilateral RPE
detachments in combination with drusenoid lesions were de-
tected in another patient. In single patients, a unilateral RPE
detachment, an old unilateral retinal venous occlusion, and
Table 1 Clinical characteristics
of the 37 phenotyped patients
who chronically used low-dose
steroids for at least the last 2 years
prior to examination
Clinical characteristics
Number of patients 37
Number of males 25 (68%)
Number of females 12 (32%)
Mean age ± SD (range) at phenotyping, in years 59 ± 11 (38–77)
Mean age ± SD (range) at renal transplantation, in years 50 ± 12 (22–71)
Reason for first transplantation
Autosomal polycystic kidney disease 8 (22%)
IgA nephropathy 7 (19%)
Unknown origin of disease 6 (16%)
Acute tubular necrosis 2 (5%)
Membranoproliferative glomerulonephritis 2 (5%)
Malignancy 2 (5%)
Reflux nephropathy 2 (5%)
Alport syndrome 1 (3%)
C3 glomerulopathy 1 (3%)
Chronic urinary tract infections 1 (3%)
Hemolytic-uremic syndrome + hypertension 1 (3%)
Medullary cystic kidney disease 1 (3%)
Oxalate nephropathy 1 (3%)
Pauci-immune crescentic glomerulonephritis 1 (3%)
Tubulointerstitial nephritis 1 (3%)
Retransplantation 4 (11%)
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unilateral RPE atrophy were detected. In patients with
(subclinical) CSC, mean SFCT on EDI-OCT was
286 ± 82 μm (range, 111–451 μm). In all eyes with retinal
abnormalities, mean SFCT on EDI-OCT was 301 ± 88 μm
(range, 111–489 μm), and mean SFCT in all eyes of patients
with either unilateral or bilateral abnormalities was
292 ± 84 μm (range, 111–489 μm). These CTs differed from
the eyes of patients in whom no abnormalities were detected
(232 ± 108 μm (range, 98–571 μm); p = 0.071, p = 0.01, and
p = 0.006 respectively).
None of the clinical characteristics of the included
patients could be linked with either the presence or ab-
sence of ocular abnormalities. Treatment was not needed
for the retinal abnormalities that were detected in this
study. For the patient with macular pseudohole and for
the patient with maculopathy with secondary vitelliform-
like lesions, additional follow-up visits were scheduled.
The retinal findings of the patients are summarized in
Table 2.
Discussion
Retinal abnormalities were found in 22 of 37 renal transplant
patients (59%), who were using chronic low-dose steroids for
at least 2 years prior to examination and who were not previ-
ously known to have chorioretinal diseases. Findings charac-
teristic for (subclinical) CSCwere found in ten patients (27%),
and two of these patients showed active SRF leakage in the
macula. Moreover, in five other patients and in a total of six
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patients (16%) an ERM was found. These findings indicate
that renal transplant patients could benefit from ophthalmo-
logical examination. The frequent occurrence of CSC-like ab-
normalities may have been caused by steroid use, which has
been described to be its most important risk factor [12, 18,
19]. In light of the underlying disease and use of
comedication, and the cross-sectional/observational nature of
this study, it remains uncertain whether a causal relation exists
between the use of steroids and the high prevalence of retinal
abnormalities in renal transplant patients. If there is a causal
relation, this might be either due to a (previous) short-term
high dosage or due to the cumulative effect of a long-term
low dosage.
Extensive ophthalmological phenotyping in renal trans-
plant patients using steroids has not been conducted so far.
The low prevalence of CSC with active SRF leakage in our
cohort (5%) is surprising, given the fact that all patients had
used high cumulative doses of steroids. This suggests that the
susceptibility for developing CSC depends on more risk fac-
tors than solely the use of steroids. Still, 22% of patients had
retinal abnormalities that may compatible with subclinical
CSC without SRF leakage. In a previous study, in which the
authors did not exclude patients with pre-existing ophthalmo-
logical diseases, and in which no ophthalmological imaging
was performed and in which exact definitions of disease were
lacking, retinal pigment epitheliopathy (14%), CSC (3%), ret-
inal vein occlusion (3%), and macular edema (3%) were de-
scribed [11]. The number of patients with retinal pigment
epitheliopathy/CSC in our study seems to be in line with these
previously published findings.
For this study, only patients who used steroids for more
than 2 years and who did not have a history of either
chorioretinal diseases or complaints that could be related to
these diagnoses were included. Since a selection based on
underlying renal pathology was not performed, patients with
various renal diseases were included. In contrast with another
study, we did not find a correlation between the outcome of
phenotyping and the duration of dialysis before transplanta-
tion and time since transplantation [11]. Other clinical charac-
teristics of the included patients could also not be linked to the
occurrence of ophthalmological abnormalities. However,
compared to patients in whom no ophthalmological abnormal-
ities were found, a significantly increased mean SFCT was
observed in patients in whom ophthalmological abnormalities
were seen. In CSC patients, the choroid is usually thicker
compared to the healthy population, strengthening the rele-
vance of this finding [20–22]. Both the increased CT and
percentage of patients with (subclinical) CSC in this study
could thus have been caused by the effect of steroids on the
choroid, in cases of administration for a prolonged period and
only in a specific patient group with predisposition to develop
these abnormalities [23, 24]. However, CT between patients
with (subclinical) CSC and patients without ophthalmological
abnormalities did not differ significantly, which may be relat-
ed to the small sample size. Since younger age, shorter axial
length, male gender, deeper anterior chamber, thicker lens,
flatter cornea, and better BCVA have all been associated with
Fig. 1 Spectrum of retinal abnormalities in renal transplant patients who
chronically used low-dose steroids for at least the last 2 years prior to
examination. a–eMultimodal imaging of a 58-year-old male patient who
received a renal transplant 21 years before phenotyping, because of
membranoproliferative glomerulonephritis. Fundus photography of the
right eye (a) showed mild foveal and extrafoveal retinal pigment
epithelium (RPE) abnormalities, and on fundus autofluorescence (FAF;
b) irregular changes were present. Fluorescein angiography of the right
eye (FA; c), which was performed after oral administration of fluorescein,
showed multifocal hyperfluorescent areas, but no clear ‘hot spot’ of
leakage. On the foveal optical coherence tomography (OCT) scan of the
right eye (d) RPE and outer photoreceptor changes suggestive of central
serous chorioretinopathy, and a subfoveal choroidal thickness (SFCT) of
451 μm were found. No subretinal fluid (SRF) was present in the right
eye. In the left eye, milder abnormalities were detected on multimodal
imaging, but extrafoveal OCT scanning (e) showed SRF nasosuperiorly
and RPE changes. f–jMultimodal imaging of a 43-year-old male patient
who was transplanted 11 years ago, because of reflux nephropathy. On
fundus photography of the right eye (f) subtle extrafoveal RPE
abnormalities were observed, with corresponding changes on FAF (g).
Mild hyperfluorescent changes were found on oral FA (h) of this eye,
partly due to staining and partly due to a window defect. The foveal (i)
and extrafoveal OCTscans (j) revealed mild outer retinal changes and the
SFCTwas 349 μm. Moreover, RPE detachments, which could also cor-
respond to age-related (subclinical) small hard drusen, were found.
Similar findings were observed in the left eye of this patient. k–o
Multimodal imaging of a 44-year-old female patient who underwent
transplantation surgery 22 years before retinal phenotyping, and had
received a t ransplan t because of membranoprol i fera t ive
glomerulonephritis. Cuticular drusen, known to be associated with
membranoproliferative glomerulonephritis type II (dense deposit
disease), were detected on fundus photography (k), FAF (l), oral FA
(m), and both foveal (n) and extrafoveal OCT images (o) of the right
eye. SFCT was 297 μm at this visit. In the left eye, identical findings
were detected. p–t Multimodal imaging of a 63-year-old male patient
who received a renal transplant 6 years before ophthalmological
phenotyping, because of IgA nephropathy, showed findings
characteristic for bilateral nonexudative age-related macular
degeneration and secondary vitelliform-like lesions. On fundus
photography of the left eye (p), yellow-white lesions and confluent
drusen were seen in the macula, together with cuticular drusen and RPE
alterations peripherally. On FAF (q) hyperfluorescent changes with an
irregular border were seen in the macular area. Oral FA (r) revealed
cuticular drusen and irregular hyperfluorescent changes foveally and
perifoveally, which could be characteristic for the vitelliform-like
lesions. Foveal (s) and extrafoveal OCT images (t) showed drusen, and
a hyperreflective subretinal accumulation, that was most pronounced
foveally. Comparable lesions were found in the other eye of this patient.
u–v In a 37-year-old male patient, who had received a renal transplant for
Alport’s disease 7 years before retinal phenotyping, fundus photography
of the right eye (u) showed multiple, small yellow-white lesions in the
midperiphery of the fundi, known to be associated with this disease.
Foveal OCT scanning (v) showed some traction of unknown origin, and
a SFCTof 489μm. Comparable lesions were found in the left eye.w–x In
a 62-year-old female patient, who was previously diagnosed with
autosomal dominant polycystic kidney disease and was transplanted
19 years ago, a unilateral foveal epiretinal membrane was detected on
OCT (w). SFCTwas 238 μm, at that visit. The epiretinal membrane was
also observed on fundus photography (x)
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an increase in SFCT, comparison of the measurements in our
patients with matched healthy controls to whom low-dose
steroids had not been prescribed chronically could have at-
tached significance to our data [25, 26].
Even though we expected to find abnormal ocular findings
in patients with chronic kidney disease, given the correlation
between nephrological and ophthalmological diseases
[27–29], the prevalence of abnormalities was higher than we
had expected beforehand. This may have been caused by the
use of other (immunosuppressive) medication, due to hyper-
tension, due to pre-existing renal diseases, or even due to
diabetes mellitus.
In conclusion, retinal abnormalities are present in the ma-
jority of renal transplant patient who use low-dose steroids
chronically. Therefore, an ophthalmological examination in-
cluding evaluation of the retina is indicated in these patients.
However, seeing that the ophthalmological abnormalities
were relatively mild and had a low likelihood for causing
symptoms and complications, the dosage of prescribed ste-
roids does not have to be lowered or discontinued in this
patient group.
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Table 2 Reason for
transplantation of the 22
phenotyped patients with retinal
abnormalities who chronically
used low-dose steroids for at least
the last 2 years prior to
examination
Retinal abnormality Reason for transplantation (number of patients)
Bilateral findings characteristic for CSC*,
bilateral SRF
Membranoproliferative glomerulonephritis (1)
Bilateral findings characteristic for CSC*,
unilateral SRF
Unknown origin of disease (1)
Bilateral findings characteristic for CSC*, no SRF Acute tubular necrosis after surgery (1), ADPKD (1),
reflux nephropathy (1), tubulointerstitial nephritis (1)
Unilateral findings characteristic for CSC*, no SRF Chronic urinary tract infections (1), hemolytic–uremic
syndrome AND hypertension (1), IgA nephropathy
(1)
Unilateral findings characteristic for CSC*, no SRF;
AND a bilateral epiretinal membrane
ADPKD (1)
Bilateral epiretinal membrane Unknown origin of disease (1)
Unilateral epiretinal membrane ADPKD (2), pauci-immune crescentic
glomerulonephritis (1)
Unilateral epiretinal membrane AND a unilateral
macular pseudohole AND bilateral choroidal folds
Nephrosclerosis AND neoplasm (1)
Bilateral cuticular drusen, known for
membranoproliferative glomerulonephritis
Membranoproliferative glomerulonephritis (1)
Bilateral dry age-related macular degeneration
AND secondary vitelliform lesions AND
cuticular drusen
IgA nephropathy (1)
Bilateral peripheral yellow-white lesions,
known for Alport syndrome
Alport syndrome (1)
Bilateral retinal pigment epithelium detachments
AND drusenoid lesions
Oxalate nephropathy (1)
Unilateral old venous occlusion Unknown origin of disease (1)
Unilateral retinal pigment epithelium atrophy Unknown origin of disease (1)
Unilateral retinal pigment epithelium detachment ADPKD (1)
No abnormalities Acute tubular necrosis after surgery (1), ADPKD (3),
C3 glomerulopathy (1), IgA nephropathy (5),
medullary cystic kidney disease (1), nephrosclerosis
AND neoplasm (1), reflux nephropathy (1),
unknown origin of disease (2)
ADPKD autosomal dominant polycystic kidney disease, CSC central serous chorioretinopathy, FA fluorescein
angiography, OCT optical coherence tomography, SRF subretinal fluid
* Outer photoreceptor/retinal pigment epithelium changes on OCT, reminiscent of changes in chronic CSC, with
corresponding hyperfluorescent changes on FA
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